MARKET

BIB

BIB

ProShares Ultra Nasdaq Biotechnology
NASDAQ
123.13
+1.00
+0.82%
After Hours: 123.29 +0.16 +0.13% 16:15 11/11 EST
OPEN
122.35
PREV CLOSE
122.13
HIGH
123.45
LOW
121.13
VOLUME
3.44K
TURNOVER
--
52 WEEK HIGH
126.31
52 WEEK LOW
70.09
TOTAL ASSET
107.35M
YTD YIELD
71.48%
1D
5D
1M
3M
1Y
5Y
1D
Halozyme downgraded at Morgan Stanley on valuation
Seeking Alpha · 4h ago
What Is Coming? - Weekly Blog #966
Seeking Alpha · 1d ago
Weekly Report: what happened at BIB last week (1102-1106)?
Weekly Report · 2d ago
Healthcare Stocks Deserve A Second Opinion
Seeking Alpha · 11/03 08:57
Weekly Report: what happened at BIB last week (1026-1030)?
Weekly Report · 11/02 09:56
Beyond The Ballot: Why Markets May Look Past U.S. Midterm Results
Seeking Alpha · 10/29 16:20
What The U.S. Midterm Elections Mean For Healthcare And Pharma
Seeking Alpha · 10/28 15:20
CIO Weekly: 3 Tests To The Equities Rally
Seeking Alpha · 10/26 10:02
More
Profile
Fund Name
ProShares Ultra Nasdaq Biotechnology
Inception Date
2010-04-06
Benchmark
NASDAQ Biotechnology TR USD
Advisor Company
ProShares
Custodian
JPMorgan Chase Bank, N.A.
Manager
Michael Neches, Tarak Davé